ArticlePloS one2020

Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT).

Mehdi Brahmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.